Tatsutoshi Nakahata

Kawasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Journal: NPJ precision oncology

Published: February 14, 2026

Improvement of multilineage hematopoiesis in hematopoietic stem cell-transferred c-kit mutant NOG-EXL humanized mice.

Improvement of multilineage hematopoiesis in hematopoietic stem cell-transferred c-kit mutant NOG-EXL humanized mice.

Journal: Stem cell research & therapy

Published: August 17, 2023

Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes.

Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes.

Journal: Communications biology

Published: March 27, 2023

Screening Station, a novel laboratory automation system for physiologically relevant cell-based assays.

Screening Station, a novel laboratory automation system for physiologically relevant cell-based assays.

Journal: SLAS technology

Published: October 07, 2022

Author Correction: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice.

Author Correction: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice.

Journal: Communications biology

Published: September 28, 2022

Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells.

Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells.

Journal: Cancer science

Published: August 30, 2022

The first Japanese biobank of patient-derived pediatric acute lymphoblastic leukemia xenograft models.

The first Japanese biobank of patient-derived pediatric acute lymphoblastic leukemia xenograft models.

Journal: Cancer science

Published: May 11, 2022

SMN promotes mitochondrial metabolic maturation during myogenesis by regulating the MYOD-miRNA axis.

SMN promotes mitochondrial metabolic maturation during myogenesis by regulating the MYOD-miRNA axis.

Journal: Life science alliance

Published: March 19, 2022

JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia.

JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia.

Journal: International journal of hematology

Published: December 27, 2021

CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia.

CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia.

Journal: Biochemical and biophysical research communications

Published: December 20, 2021

iPS cells from Chediak-Higashi syndrome patients recapitulate the giant granules in myeloid cells.

iPS cells from Chediak-Higashi syndrome patients recapitulate the giant granules in myeloid cells.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: December 05, 2021

RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.

RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors.

Journal: Molecules and cells

Published: November 23, 2021

Showing 1-12 of 106

Last Updated: 09/26/2026